In Brief: FDA's Circulatory System Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA's Circulatory System Devices Panel: Scheduled to meet on Aug. 21 and 22. On Aug. 21 the panel will review a PMA for an automatic cardiac defibrillator. On Aug. 22, the committee will consider reclassification of human heart valve allografts and centrifugal blood pumps for short-term use. Contact Ramiah Subramanian at 301/443-0572 for more information...